May 2024 FDA Recall Phenazopyridine Hydrochloride by Winder Laboratories, Llc
D-0545-2024 - Product Mix Up. A bottle of Phenazopyridine HCl tablets USP 100 mg contained Phenobarbital tablets 16.2 mg.

This Class II drug recall was voluntarily initiated by Winder Laboratories, Llc on May 28, 2024 for the product Phenazopyridine Hydrochloride. The FDA reported the reason for recall as product mix up. a bottle of phenazopyridine hcl tablets usp 100 mg contained phenobarbital tablets 16.2 mg.. The product was distributed Nationwide and the recall is currently completed.

Recall Number: D-0545-2024

Reason for Recall
Product Mix Up. A bottle of Phenazopyridine HCl tablets USP 100 mg contained Phenobarbital tablets 16.2 mg.
Initiated
05-28-2024
Reported
06-19-2024
Quantity
473 cases (5676 Bottles)

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Winder Laboratories, LLC
Nationwide within the United States
Phenazopyridine HCl Tablets USP, 100 mg, 100-count bottles, Rx Only, Manufactured by: Winder Laboratories, LLC. 716 Patrick Industrial Lane, Winder, GA 30680, NDC 75826-114-10,

Batch or Lot Expiration Information

Lot# : 1142404 Exp. Date 02/27/2027